PP84 From Regulatory Approval To Public Health System Coverage: Overcoming Challenges For Timely Access To Oncology Drugs In Brazil
Stéfani Borges, Mateus Cerqueira, Gustavo Frio, Bruna Santos, Ivan Zimmermann · 2025
Read PP84 From Regulatory Approval To Public Health System Coverage: Overcoming Challenges For Timely Access To Oncology Drugs In Brazil by Stéfani Borges, Mateus Cerqueira, Gustavo Frio, Bruna Santos, Ivan Zimmermann (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12768814.txt.
Description
Stefani Borges and co-authors measure the gap between drug approval and public coverage for cancer medicines in Brazil, in a 2025 study. A drug can clear regulators yet wait years before the public system pays for it. Patients feel that delay directly. The team mapped what drives the lag.
Records came from the national technology committee's reports for drugs approved for coverage from 2019 to 2023. Dates of approval and coverage were paired for each drug. Request origin, drug class, and price were also logged. The average gap was then charted across these factors. Findings of this kind point to where the path from approval to access can be shortened.
Catalog record
| CREATOR | Stéfani Borges, Mateus Cerqueira, Gustavo Frio, Bruna Santos, Ivan Zimmermann |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |